Understanding Dapagliflozin: Examining Its Use in Chronic Kidney Disease episode artwork

EPISODE · Feb 23, 2021 · 12 MIN

Understanding Dapagliflozin: Examining Its Use in Chronic Kidney Disease

from Diabetes Discourse

Host: John Buse, MD, PhD Guest: David Wheeler, MB, CHB, MD, FRCP Recent research has revealed that a type 2 diabetes treatment may help manage chronic kidney disease. Dr. John Buse discusses the use of dapagliflozin in patients with chronic kidney disease with Dr. David Wheeler, a professor of kidney medicine at the University College London in the United Kingdom, and an honorary consultant nephrologist at the Royal Free London NHS Foundation Trust.

Episode metadata supplied by the publisher feed · Published Feb 23, 2021

Embed this episode

NOW PLAYING

Understanding Dapagliflozin: Examining Its Use in Chronic Kidney Disease

0:00 12:30

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Diabetes Discourse?

This episode is 12 minutes long.

When was this Diabetes Discourse episode published?

This episode was published on February 23, 2021.

Can I download this Diabetes Discourse episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!